Increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the global glycomics/glycobiology market.
- Agency -.
The Global Glycomics/Glycobiology Market is poised to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. The glycomics/glycobiology market is segmented on the basis of product, application, end user, and region.
On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents.
- Agency -.
This growth is mainly attributed to their consumable nature and wide applications in a variety of R&D and drug discovery procedures. The enzymes segment is further divided into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes.
Click Now for request Sample Download of this Study Report
Target Audience for this Report:
- Glycomics enzymes, kits, reagents, and instruments manufacturers and vendors
- Associations related to glycomics enzymes, kits, and reagents
- Research institutes and contract research organizations (CROs)
- Market research and consulting firms
- Life sciences instrumentation and reagent companies
- Pharmaceutical and biotechnology companies
- Clinical research institutes
On the basis of application, the market is segmented into diagnostics, drug discovery & development, oncology, immunology, and other applications. In 2016, the drug discovery and development segment is expected to account for the largest share of the market.
This growth can be attributed to increase in R&D activities for the development of novel drugs and therapies.
On the basis of region, the market is segmented into North America, Asia, Europe, and RoW. The Asian market is estimated to grow at the highest CAGR during the forecast period.
This growth is mainly attributed to the increasing commercialization of R&D by pharmaceutical and biotechnology companies, growing demand for personalized medicine, and rising importance of companion diagnostics.
3 Executive Summary
4 Premium Insights
4.1 Glycomics: Market Overview (2016-2021)
4.2 Geographic Analysis: Glycomics Market, By Product
4.3 Life Cycle Analysis, By Region.
Report on glycomics/glycobiology Market spread across 192 Pages, Profiling 11 Companies and Supported with 135 Tables and 38 Figures is now available at www.rnrmarketresearch.com/contacts…ount?rname=216467
Company Profiles(Overview, Products and Services, Financials, Strategy & Development)*
Merck KGaA, Takara Bio, Inc, Shimadzu Corporation, Bruker Corporation, Waters Corporation, New England Biolabs Inc, Agilent Technologies, Inc, Danaher Corporation, ProZyme, Inc, Thermo Fisher Scientific, Inc.*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.
Access this research report available at www.reportsnreports.com/contacts/d….aspx?name=299618
Reasons to Access the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a higher market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: